| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |